Creative Medical Technology Holdings CELZ
NASDAQ CELZ
$1.04 -0.04 (-3.70%)
At close: Sep 9, 2026 · 4:00 PM EDT

Creative Medical Technology Holdings (CELZ) Assets Average (2011 - 2026)

Creative Medical Technology Holdings' (CELZ) quarterly Assets Average came in at $7.9 million in Q2 2026, up 2.37% year-over-year from $7.7 million in Q2 2025, and up 11.0% quarter-over-quarter from $7.1 million in Q1 2026.

Analysis

Creative Medical Technology Holdings (CELZ) Assets Average (2011 - 2026) Analysis & Trends

Creative Medical Technology Holdings (CELZ) has reported Assets Average for 16 consecutive years, with $7.9 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Assets Average rose 2.37% year-over-year to $7.9 million in Q2 2026; TTM through Jun 2026 was $7.9 million, a 2.37% increase from a year earlier, with the FY2025 full-year figure at $7.2 million, down 16.71% from the prior year.
  • Assets Average was $7.9 million for Q2 2026 at Creative Medical Technology Holdings, up from $7.1 million in the prior quarter.
  • Over five years, Assets Average peaked at $23.0 million in Q3 2022 and troughed at $6.5 million in Q3 2025.
  • A 5-year average of $11.4 million and a median of $9.5 million in 2024 frame the typical range for Assets Average.
  • Across the five-year window, Assets Average jumped 1967.6% in 2022 and plunged 44.23% in 2023, its largest moves.
  • Over 5 years, Assets Average stood at $20.8 million in 2022, then sank by 44.23% to $11.6 million in 2023, then sank by 41.64% to $6.8 million in 2024, then climbed by 0.78% to $6.8 million in 2025, then advanced by 15.78% to $7.9 million in 2026.
  • The last three Assets Average figures came in at $7.9 million (Q2 2026), $7.1 million (Q1 2026), and $6.8 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Krystal Biotech 10.27 Bn 9.43 Bn 112.79 Mn 1.45 Bn
2 CRISPR Therapeutics AG 5.17 Bn 5.17 Bn - 2.69 Bn
3 Iovance Biotherapeutics 3.79 Bn 3.49 Bn 55.72 Mn 920.60 Mn
4 Legend Biotech 3.68 Bn 2.71 Bn 251.50 Mn 1.67 Bn
5 uniQure 3.05 Bn 3.05 Bn 5.49 Mn 881.90 Mn
6 Beam Therapeutics 2.65 Bn 2.65 Bn - 1.43 Bn
7 Precigen 2.44 Bn 2.44 Bn 52.17 Mn 154.46 Mn
8 Sarepta Therapeutics 2.33 Bn 1.53 Bn 251.87 Mn 3.18 Bn
9 Vericel 1.99 Bn 1.83 Bn 56.40 Mn 494.25 Mn
10 Creative Medical Technology Holdings 1.45 Mn 1.45 Mn - 7.91 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.91 Mn
Mar 31, 2026 7.13 Mn
Dec 31, 2025 6.83 Mn
Sep 30, 2025 6.48 Mn
Jun 30, 2025 7.73 Mn
Mar 31, 2025 7.51 Mn
Dec 31, 2024 6.78 Mn
Sep 30, 2024 7.44 Mn
Jun 30, 2024 8.80 Mn
Mar 31, 2024 10.17 Mn
Dec 31, 2023 11.61 Mn
Sep 30, 2023 13.32 Mn
Jun 30, 2023 14.68 Mn
Mar 31, 2023 17.21 Mn
Dec 31, 2022 20.83 Mn
Sep 30, 2022 22.95 Mn
Jun 30, 2022 16.58 Mn
Mar 31, 2022 10.50 Mn
Dec 31, 2021 7.20 Mn
Sep 30, 2021 1.93 Mn